Talbot Financial LLC Buys Shares of 21,130 Aspen Aerogels, Inc. (NYSE:ASPN)

Talbot Financial LLC bought a new stake in Aspen Aerogels, Inc. (NYSE:ASPN) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 21,130 shares of the construction company’s stock, valued at approximately $251,000.

Other institutional investors have also recently added to or reduced their stakes in the company. FMR LLC boosted its stake in shares of Aspen Aerogels by 23.6% during the third quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock valued at $112,169,000 after acquiring an additional 773,647 shares during the last quarter. Driehaus Capital Management LLC boosted its stake in shares of Aspen Aerogels by 130.4% during the second quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock valued at $51,439,000 after acquiring an additional 1,220,724 shares during the last quarter. Loomis Sayles & Co. L P boosted its stake in shares of Aspen Aerogels by 22.7% during the third quarter. Loomis Sayles & Co. L P now owns 1,619,320 shares of the construction company’s stock valued at $44,839,000 after acquiring an additional 300,076 shares during the last quarter. State Street Corp boosted its stake in shares of Aspen Aerogels by 0.6% during the third quarter. State Street Corp now owns 1,410,543 shares of the construction company’s stock valued at $39,058,000 after acquiring an additional 8,344 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of Aspen Aerogels by 5.7% during the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock valued at $38,385,000 after acquiring an additional 75,024 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

ASPN has been the topic of a number of research analyst reports. Barclays decreased their price target on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 12th. StockNews.com raised Aspen Aerogels to a “sell” rating in a research note on Wednesday, November 13th. HC Wainwright reissued a “buy” rating and issued a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Piper Sandler decreased their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Finally, Roth Mkm decreased their price target on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $30.00.

Aspen Aerogels Stock Down 0.6 %

Shares of NYSE ASPN traded down $0.08 on Monday, hitting $12.46. The company had a trading volume of 949,390 shares, compared to its average volume of 1,475,738. Aspen Aerogels, Inc. has a 12-month low of $10.75 and a 12-month high of $33.15. The business has a 50 day moving average of $13.94 and a two-hundred day moving average of $20.58. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $1.02 billion, a P/E ratio of 1,247.25 and a beta of 2.14.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.